本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Drugs Made In America Acquisition Corp

10.84
0.0000
成交量:8
成交額:86.58
市值:2.63億
市盈率:58.69
高:10.84
開:10.84
低:10.84
收:10.84
52周最高:10.86
52周最低:10.26
股本:2,427.69萬
流通股本:1,968.81萬
量比:0.00
換手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):0.1847
每股收益(LYR):0.1878
淨資產收益率:--
總資產收益率:-1.46%
市淨率:1.16
市盈率(LYR):57.73

資料載入中...

2026/09/15

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/09/15

重要事件披露

Form 8-K - Current report
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/07/20

重要事件披露

Form 8-K - Current report
2026/06/26

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/04/08

重要事件披露

Form 8-K - Current report
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/06

重要事件披露

Form 8-K - Current report